menu
    • menu

    Company profile for Peptron

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Since its foundation in 1997, Peptron Inc. has developed the fundamental technologies for peptide-based medicines. In line with proprietary technologies, we are developing sustained-release medications with a high technological entrance barrier and excellent product competitiveness, to treat life threatening and chronic diseases. PeptrEXTM and SmartDepotTM, our two most representative technologies, help to transform the initi...
    Since its foundation in 1997, Peptron Inc. has developed the fundamental technologies for peptide-based medicines. In line with proprietary technologies, we are developing sustained-release medications with a high technological entrance barrier and excellent product competitiveness, to treat life threatening and chronic diseases. PeptrEXTM and SmartDepotTM, our two most representative technologies, help to transform the initial research process to the final medication development and successful commercialization phases. During the 15 years of research and development process we accumulated extensive know-how.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Peptronkorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    37-24, Yuseong-daero 1628 beon-gil, Yuseong-gu, Daejeon, 305-811
    Telephone
    Telephone
    +82-42-360-8880
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.peptron.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Peptron's PT105 established the bioequivalence with Takeda's Leuplin
    Peptron's PT105 established the bioequivalence with Takeda's Leuplin

    28 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/peptrons-pt105-a-sustained-release-leuprolide-established-the-bioequivalence-with-takedas-leuplin-301687409.html

    PRNEWSWIRE
    28 Nov 2022
    Share Share
    Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC
    Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC

    16 Apr 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/qilu-pharmaceutical-and-peptron-sign-license-agreement-for-anti-muc1-adc-301270464.html

    PRNEWSWIRE
    16 Apr 2021
    Share Share
    Repurposing a diabetes drug to slow Parkinson’s
    Repurposing a diabetes drug to slow Parkinson’s

    23 Jul 2018

    // Bradley J. Fikes FIERCE BIOTECH

    https://www.fiercebiotech.com/research/repurposing-glp-1-diabetes-drug-to-slow-parkinson-s-disease

    Bradley J. Fikes FIERCE BIOTECH
    23 Jul 2018
    Share Share
    New SR Exendin-4 Formulation proves effective against Parkinson's
    New SR Exendin-4 Formulation proves effective against Parkinson's

    16 Jul 2018

    // BIOSPECTRUM

    https://www.biospectrumasia.com/news/25/11292/new-sr-exendin-4-formulation-proves-effective-against-parkinsons.html

    BIOSPECTRUM
    16 Jul 2018
    Share Share
    Peptron Expands Exclusive License with NIH to Support Developing SR-exenatide
    Peptron Expands Exclusive License with NIH to Support Developing SR-exenatide

    23 Apr 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/peptron-expands-exclusive-license-with-nih-to-support-developing-sr-exenatide-to-treat-neurodegenerative-diseases-300633519.html

    PR NEWSWIRE
    23 Apr 2018
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search